- Home
- LNSR vs TARA Comparison
LNSR vs TARA Comparison
Compare LNSR & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNSR
- TARA
- Stock Information
- Founded
- LNSR 2004
- TARA N/A
- Country
- LNSR United States
- TARA United States
- Employees
- LNSR N/A
- TARA N/A
- Industry
- LNSR Medical Electronics
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LNSR Health Care
- TARA Health Care
- Exchange
- LNSR Nasdaq
- TARA Nasdaq
- Market Cap
- LNSR 63.4M
- TARA 52.4M
- IPO Year
- LNSR N/A
- TARA N/A
- Fundamental
- Price
- LNSR $7.08
- TARA $2.47
- Analyst Decision
- LNSR
- TARA Strong Buy
- Analyst Count
- LNSR 0
- TARA 2
- Target Price
- LNSR N/A
- TARA $24.00
- AVG Volume (30 Days)
- LNSR 43.8K
- TARA 235.4K
- Earning Date
- LNSR 11-07-2024
- TARA 11-12-2024
- Dividend Yield
- LNSR N/A
- TARA N/A
- EPS Growth
- LNSR N/A
- TARA N/A
- EPS
- LNSR N/A
- TARA N/A
- Revenue
- LNSR $48,868,000.00
- TARA N/A
- Revenue This Year
- LNSR $25.07
- TARA N/A
- Revenue Next Year
- LNSR $24.95
- TARA N/A
- P/E Ratio
- LNSR N/A
- TARA N/A
- Revenue Growth
- LNSR 21.29
- TARA N/A
- 52 Week Low
- LNSR $2.10
- TARA $1.04
- 52 Week High
- LNSR $7.96
- TARA $5.24
- Technical
- Relative Strength Index (RSI)
- LNSR 65.23
- TARA 57.56
- Support Level
- LNSR $6.52
- TARA $2.43
- Resistance Level
- LNSR $7.66
- TARA $2.74
- Average True Range (ATR)
- LNSR 0.62
- TARA 0.19
- MACD
- LNSR 0.10
- TARA -0.00
- Stochastic Oscillator
- LNSR 67.29
- TARA 45.23
About LNSR LENSAR Inc.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency and reproducibility by providing imaging, simplified procedure planning, efficient design and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. The consumable portion of the system consists of a disposable patient interface device, or PID, kit and a procedure license. Each procedure on each system requires the use of a PID kit.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).